Split History
ETFs Holding ZSAN »    ZSAN Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zosano Pharma is a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using its proprietary intracutaneous microneedle system (the System). Co.'s development activities are focused on its product candidate, Qtrypta™ (M207). Qtrypta™ (M207) is Co.'s proprietary formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is one of a class of serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta™ (M207) is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal tract. According to our ZSAN split history records, Zosano Pharma has had 1 split.
ZSAN split history picture
Zosano Pharma (ZSAN) has 1 split in our ZSAN split history database. The split for ZSAN took place on January 26, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of ZSAN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Zosano Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ZSAN split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zosano Pharma shares, starting with a $10,000 purchase of ZSAN, presented on a split-history-adjusted basis factoring in the complete ZSAN split history. ZSAN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/27/2015
End date: 06/18/2021
Start price/share: $220.20
End price/share: $0.98
Dividends collected/share: $0.00
Total return: -99.55%
Average Annual Total Return: -57.14%
Starting investment: $10,000.00
Ending investment: $44.48
Years: 6.39
Date Ratio
01/26/20181 for 20
ZSAN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

A Split History
AAC Split History
ABC Split History
ABIO Split History
ABMD Split History
ABT Split History
ABV Split History
ACER Split History
ACET Split History
ACHC Split History

Also explore: ZSAN shares outstanding history

BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
Horizons NASDAQ-100 Index ETF (HXQ)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ZSAN Insider Buying

ZSAN Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.